Market Cap ₹202 Cr.
Stock P/E 12.6
P/B 0.9
Current Price ₹405
Book Value ₹ 438.1
Face Value 10
52W High ₹619
Dividend Yield 0.67%
52W Low ₹ 321.1
The United Nilgiri Tea Estates Company Limited is a company that produces and exports tea leaves from its estates in the Nilgiris, a mountain range in southern India. The company was founded in 1922 by Sir Robert Stanes and is part of the Amalgamations Group. The company has four estates, namely Chamraj, Allada Valley, Devabetta, and Korakundah, that produce orthodox, black, green, decaffeinated, herbal, aroma, flavoured, and iced teas. It markets teas under the brands Chamraj and Korakundah and also exports to various countries. The company is one of the pioneers and industry leaders in organic tea production and has received several international awards and recognitions for its quality and sustainability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 23 | 20 | 17 | 19 | 19 | 24 | 22 | 23 | 25 | 23 |
Other Income | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 2 |
Total Income | 25 | 22 | 19 | 21 | 21 | 25 | 24 | 25 | 28 | 25 |
Total Expenditure | 20 | 17 | 14 | 14 | 15 | 19 | 19 | 20 | 20 | 19 |
Operating Profit | 5 | 5 | 4 | 7 | 6 | 6 | 5 | 5 | 8 | 6 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 4 | 4 | 3 | 6 | 5 | 6 | 4 | 4 | 7 | 5 |
Provision for Tax | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Profit After Tax | 3 | 3 | 3 | 5 | 4 | 4 | 3 | 4 | 6 | 5 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
Profit After Adjustments | 3 | 3 | 3 | 5 | 4 | 4 | 3 | 4 | 6 | 5 |
Adjusted Earnings Per Share | 6 | 5.7 | 5.6 | 9.7 | 7.8 | 8.6 | 6.1 | 7.5 | 12.9 | 9 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 49 | 51 | 57 | 54 | 62 | 66 | 63 | 66 | 76 | 84 | 84 | 93 |
Other Income | 1 | 2 | 2 | 2 | 5 | 4 | 4 | 8 | 5 | 5 | 8 | 9 |
Total Income | 50 | 52 | 59 | 57 | 67 | 70 | 67 | 74 | 81 | 89 | 92 | 102 |
Total Expenditure | 38 | 39 | 42 | 42 | 49 | 52 | 50 | 56 | 65 | 70 | 68 | 78 |
Operating Profit | 12 | 14 | 16 | 15 | 18 | 18 | 17 | 19 | 16 | 19 | 24 | 24 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 4 | 4 | 4 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 10 | 11 | 14 | 12 | 15 | 17 | 14 | 15 | 13 | 15 | 20 | 20 |
Provision for Tax | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 |
Profit After Tax | 8 | 9 | 10 | 9 | 12 | 14 | 11 | 12 | 10 | 12 | 16 | 18 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 8 | 9 | 10 | 9 | 12 | 14 | 11 | 12 | 10 | 12 | 16 | 18 |
Adjusted Earnings Per Share | 15.5 | 17.4 | 20.5 | 18.3 | 24.3 | 28.8 | 21.4 | 24.5 | 20.6 | 24.2 | 32.1 | 35.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 8% | 5% | 6% |
Operating Profit CAGR | 26% | 8% | 6% | 7% |
PAT CAGR | 33% | 10% | 3% | 7% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 16% | -0% | 13% | 8% |
ROE Average | 8% | 7% | 7% | 11% |
ROCE Average | 10% | 9% | 9% | 14% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 52 | 59 | 68 | 102 | 117 | 139 | 154 | 166 | 175 | 187 | 204 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 4 | 4 | 5 | 6 |
Total Current Liabilities | 9 | 7 | 9 | 5 | 21 | 23 | 27 | 30 | 32 | 28 | 31 |
Total Liabilities | 63 | 68 | 79 | 108 | 140 | 165 | 184 | 200 | 212 | 220 | 241 |
Fixed Assets | 36 | 38 | 38 | 20 | 21 | 21 | 28 | 27 | 28 | 30 | 30 |
Other Non-Current Assets | 3 | 2 | 2 | 60 | 80 | 87 | 105 | 106 | 116 | 124 | 137 |
Total Current Assets | 24 | 28 | 38 | 29 | 39 | 57 | 51 | 66 | 68 | 66 | 74 |
Total Assets | 63 | 68 | 79 | 108 | 140 | 165 | 184 | 200 | 212 | 220 | 241 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 3 | 3 | 2 | 3 | 1 | 1 | 4 | 2 | 3 | 3 |
Cash Flow from Operating Activities | 9 | 8 | 11 | 9 | 6 | 11 | 8 | 9 | 5 | 15 | 8 |
Cash Flow from Investing Activities | -6 | -7 | -10 | -7 | -6 | -10 | -4 | -9 | -3 | -13 | -4 |
Cash Flow from Financing Activities | -1 | -2 | -2 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -2 |
Net Cash Inflow / Outflow | 2 | -0 | -1 | 1 | -2 | -1 | 3 | -2 | 1 | 0 | 2 |
Closing Cash & Cash Equivalent | 3 | 3 | 2 | 3 | 1 | 1 | 4 | 2 | 3 | 3 | 5 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 15.53 | 17.41 | 20.47 | 18.34 | 24.32 | 28.76 | 21.44 | 24.51 | 20.59 | 24.25 | 32.13 |
CEPS(Rs) | 19.82 | 22.36 | 25.81 | 23.63 | 29.63 | 34.2 | 26.98 | 31.77 | 27.59 | 31.55 | 39.16 |
DPS(Rs) | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 1.7 | 2.7 | 3.7 | 2.7 | 2.7 |
Book NAV/Share(Rs) | 104.61 | 118.2 | 135.42 | 203.16 | 233.25 | 278.92 | 309.2 | 331.32 | 350.77 | 374.48 | 408.74 |
Core EBITDA Margin(%) | 22.6 | 23.77 | 25.03 | 22.85 | 20.97 | 21.38 | 20.35 | 16.28 | 14.68 | 16.45 | 19.55 |
EBIT Margin(%) | 20.58 | 22.25 | 23.88 | 22.29 | 24.86 | 25.99 | 22.17 | 22.9 | 17.16 | 17.96 | 24.37 |
Pre Tax Margin(%) | 20.44 | 22.17 | 23.87 | 22.17 | 24.75 | 25.88 | 22.09 | 22.82 | 17.03 | 17.84 | 24.25 |
PAT Margin (%) | 15.76 | 17.14 | 18.01 | 16.66 | 19.65 | 21.88 | 17.05 | 18.46 | 13.6 | 14.48 | 19.11 |
Cash Profit Margin (%) | 20.11 | 22.02 | 22.71 | 21.46 | 23.95 | 26.01 | 21.46 | 23.93 | 18.22 | 18.85 | 23.29 |
ROA(%) | 12.8 | 13.24 | 13.92 | 9.78 | 9.78 | 9.41 | 6.12 | 6.37 | 5 | 5.61 | 6.96 |
ROE(%) | 15.78 | 15.62 | 16.14 | 10.83 | 11.14 | 11.23 | 7.29 | 7.65 | 6.04 | 6.69 | 8.2 |
ROCE(%) | 20.36 | 20.18 | 21.4 | 14.5 | 14.1 | 13.34 | 9.48 | 9.49 | 7.62 | 8.29 | 10.46 |
Receivable days | 27.56 | 36.02 | 33.18 | 25.12 | 21.83 | 27.16 | 33.83 | 33.21 | 31.64 | 29.79 | 39.71 |
Inventory Days | 18.68 | 19.26 | 18.79 | 23.94 | 27.44 | 31.23 | 37.6 | 46.9 | 48.25 | 36.38 | 29.64 |
Payable days | 76.15 | 93.98 | 108.8 | 66.08 | 26.63 | 34.08 | 49.99 | 53.13 | 53.2 | 37.21 | 36.73 |
PER(x) | 16.41 | 11.14 | 19.88 | 19.79 | 14.06 | 10.97 | 9 | 12.16 | 16.42 | 11.12 | 9.84 |
Price/Book(x) | 2.44 | 1.64 | 3 | 1.79 | 1.47 | 1.13 | 0.62 | 0.9 | 0.96 | 0.72 | 0.77 |
Dividend Yield(%) | 1.06 | 1.39 | 0.66 | 0.74 | 0.79 | 0.86 | 0.88 | 0.91 | 1.09 | 1 | 0.85 |
EV/Net Sales(x) | 2.35 | 1.6 | 3.19 | 2.99 | 2.65 | 2.13 | 1.37 | 2.1 | 2.09 | 1.54 | 1.79 |
EV/Core EBITDA(x) | 9.42 | 5.89 | 11.14 | 10.92 | 9.06 | 7.7 | 5.14 | 7.41 | 9.59 | 6.88 | 6.28 |
Net Sales Growth(%) | 33.67 | 3.1 | 11.89 | -3.85 | 13.16 | 6.56 | -4.38 | 5.57 | 14.08 | 10.57 | 0.43 |
EBIT Growth(%) | 39.56 | 11.48 | 20.08 | -9.59 | 25.34 | 11.08 | -18.42 | 9.03 | -14.49 | 15.69 | 36.28 |
PAT Growth(%) | 35.08 | 12.08 | 17.59 | -10.4 | 32.6 | 18.29 | -25.47 | 14.32 | -15.98 | 17.75 | 32.5 |
EPS Growth(%) | 35.08 | 12.08 | 17.59 | -10.4 | 32.6 | 18.29 | -25.47 | 14.32 | -15.98 | 17.75 | 32.5 |
Debt/Equity(x) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 2.68 | 3.96 | 4.16 | 5.78 | 1.8 | 2.46 | 1.84 | 2.22 | 2.11 | 2.37 | 2.4 |
Quick Ratio(x) | 2.42 | 3.52 | 3.85 | 4.92 | 1.57 | 2.19 | 1.6 | 1.87 | 1.82 | 2.11 | 2.19 |
Interest Cover(x) | 144.12 | 273.48 | 4676.55 | 189.81 | 225.02 | 239.11 | 281.37 | 301.89 | 126.93 | 146.85 | 206.59 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 49.79 | 49.79 | 49.79 | 49.79 | 49.79 | 49.79 | 49.79 | 49.79 | 49.79 | 49.79 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 9.26 | 7.49 | 7.19 | 4.89 | 4.41 | 4.41 | 4.41 | 4.41 | 3.92 | 3.92 |
Public | 40.94 | 42.72 | 43.02 | 45.32 | 45.8 | 45.8 | 45.8 | 45.8 | 46.28 | 46.28 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.05 | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Public | 0.2 | 0.21 | 0.21 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About